Tune in NOW for the #AUA21 International Prostate Forum for a fantastic program with the latest evidence and practice in #ProstateCancer - starting with our panel on screening & genetic risk assessment aua2021.app.swapcard.com/eve…
CHEERS trial at #ESTRO2021 presented by @MathieuSpaas: IO vs IO SABR. Up to 3 lesions received 3x8Gy => no effect on PFS, clearly safe. Say “bye, bye to the “abscopal”-effect or did we do smth wrong? Supported by @komop_tgkanker @VarianMedSys
Wednesday's webinar will review an original research article which compares in-bore to fusion biopsy in PI-RADS category 4 and 5 lesions at a single-center with propensity scoring.
arrs.org/ajrlive
Wednesday's webinar will review an original research article which compares in-bore to fusion biopsy in PI-RADS category 4 and 5 lesions at a single-center with propensity scoring.
arrs.org/ajrlive